Statistics

Total Visits

Views
JEVTCC: Phase II trial of cabazitaxel (Cbz) in patients (pt) with advanced or metastatic transitional-cell carcinoma (mTCC), who progressed before 12 months after cisplatin-based chemotherapy-A Spanish Oncologic Genitourinary Group (SOGUG) study25

Select a period of time:

Number of views in the range

Views
JEVTCC: Phase II trial of cabazitaxel (Cbz) in patients (pt) with advanced or metastatic transitional-cell carcinoma (mTCC), who progressed before 12 months after cisplatin-based chemotherapy-A Spanish Oncologic Genitourinary Group (SOGUG) study9

Views

Views
January 20250
February 20251
March 20254
April 20252
May 20250
June 20252
July 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States4
Singapore4
Spain1
 

Top cities views

Views
Avondale1
Council Bluffs1
Winston-Salem1